End-of-Life Care: Its Cost in Heart Failure

2010 ◽  
Vol 3 (7) ◽  
pp. 6
Author(s):  
SIDNEY GOLDSTEIN
Keyword(s):  
Heart Failure ◽  
End Of Life ◽  
End Of Life Care ◽  
Life Care

Heart failure: support at the end of life

2019 ◽  
Vol 28 (10) ◽  
pp. 653-653 ◽  
Author(s):  
Aysha Mendes
Keyword(s):  
Heart Failure ◽  
British Journal ◽  
End Of Life ◽  
End Of Life Care ◽  
Life Care

Aysha Mendes, Editor, British Journal of Cardiac Nursing, begins a series on cardiology with a look at attitudes to and guidelines on providing end-of-life care for people with heart failure

scholarly journals Heart Failure in Adult Congenital Heart Disease: From Advanced Therapies to End-of-Life Care

2019 ◽  
Vol 35 (12) ◽  
pp. 1723-1739 ◽  
Author(s):  
David S. Crossland ◽  
Alexander Van De Bruaene ◽  
Candice K. Silversides ◽  
Edward J. Hickey ◽  
S. Lucy Roche
Keyword(s):  
Heart Failure ◽  
Congenital Heart Disease ◽  
Heart Disease ◽  
End Of Life ◽  
End Of Life Care ◽  
Congenital Heart ◽  
Adult Congenital Heart Disease ◽  
Life Care ◽  
Advanced Therapies ◽  
Adult Congenital

End-of-life care in patients with advanced heart failure

2020 ◽  
Vol 35 (2) ◽  
pp. 156-161 ◽  
Author(s):  
Michael J. Diamant ◽  
Hesam Keshmiri ◽  
Mustafa Toma
Keyword(s):  
Heart Failure ◽  
End Of Life ◽  
End Of Life Care ◽  
Advanced Heart Failure ◽  
Life Care

scholarly journals The Effect of Advance Care Planning on Heart Failure: a Systematic Review and Meta-analysis

2019 ◽  
Vol 35 (3) ◽  
pp. 874-884 ◽  
Author(s):  
Markus Schichtel ◽  
Bee Wee ◽  
Rafael Perera ◽  
Igho Onakpoya
Keyword(s):  
Heart Failure ◽  
End Of Life ◽  
Advance Care Planning ◽  
End Of Life Care ◽  
Meta Analysis ◽  
Care Planning ◽  
Life Care ◽  
Advance Care

Abstract Background Advance care planning is widely advocated to improve outcomes in end-of-life care for patients suffering from heart failure. But until now, there has been no systematic evaluation of the impact of advance care planning (ACP) on clinical outcomes. Our aim was to determine the effect of ACP in heart failure through a meta-analysis of randomized controlled trials (RCTs). Methods We searched CINAHL, Cochrane Central Register of Controlled Trials, Database of Systematic Reviews, Embase, ERIC, Ovid MEDLINE, Science Citation Index and PsycINFO (inception to July 2018). We selected RCTs including adult patients with heart failure treated in a hospital, hospice or community setting. Three reviewers independently screened studies, extracted data, assessed the risk of bias (Cochrane risk of bias tool) and evaluated the quality of evidence (GRADE tool) and analysed interventions according to the Template for Intervention Description and Replication (TIDieR). We calculated standardized mean differences (SMD) in random effects models for pooled effects using the generic inverse variance method. Results Fourteen RCTs including 2924 participants met all of the inclusion criteria. There was a moderate effect in favour of ACP for quality of life (SMD, 0.38; 95% CI [0.09 to 0.68]), patients’ satisfaction with end-of-life care (SMD, 0.39; 95% CI [0.14 to 0.64]) and the quality of end-of-life communication (SMD, 0.29; 95% CI [0.17 to 0.42]) for patients suffering from heart failure. ACP seemed most effective if it was introduced at significant milestones in a patient’s disease trajectory, included family members, involved follow-up appointments and considered ethnic preferences. Several sensitivity analyses confirmed the statistically significant direction of effect. Heterogeneity was mainly due to different study settings, length of follow-up periods and compositions of ACP. Conclusions ACP improved quality of life, patient satisfaction with end-of-life care and the quality of end-of-life communication for patients suffering from heart failure and could be most effective when the right timing, follow-up and involvement of important others was considered.

Sign in / Sign up

Export Citation Format

Share Document